Filing Details
- Accession Number:
- 0001415889-25-008281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-17 21:50:37
- Reporting Period:
- 2024-03-26
- Filing Date:
- 2025-03-17
- Accepted Time:
- 2025-03-17 21:50:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818331 | Genedx Holdings Corp. | WGS | Services-Health Services (8000) | 851966622 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1944119 | Kevin Feeley | C/O Genedx Holdings Corp. 333 Ludlow St, North Tower, 6Th Floor Stamford CT 06902 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2025-03-13 | 402 | $90.05 | 5,044 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2025-03-16 | 7,197 | $0.00 | 12,241 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2025-03-17 | 3,749 | $96.71 | 8,492 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Restricted Stock Unit | Acquisiton | 2024-03-26 | 65,000 | $0.00 | 65,000 | $0.00 |
| Class A Common Stock | Restricted Stock Unit | Acquisiton | 2025-03-15 | 15,261 | $0.00 | 15,261 | $0.00 |
| Class A Common Stock | Restricted Stock Unit | Disposition | 2025-03-16 | 7,197 | $0.00 | 7,197 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 65,000 | No | 4 | A | Direct | ||
| 15,261 | No | 4 | A | Direct | ||
| 57,575 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell tocover" transaction
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.67 to $96.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- On March 26, 2024, Kevin Feeley was granted an RSU award for 65,000 RSUs. 25% of the underlying restricted stock units each vests annually, commencing on March 26, 2025, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- 25% of the underlying restricted stock units each vests annually, commencing on March 15, 2026, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Billionaire Hedge Funds
